Product

FRSW107

Aliases

Recombinant Human Coagulation Factor Ⅷ，Fc Fusion Protein for Injection

2 clinical trials

1 indication

Indication

Clinical trial

An Open, Multicenter Phase III Clinical Study to Evaluate the Efficacy and Safety of Recombinant Human Coagulation Factor Ⅷ-Fc Fusion Protein (FRSW107) for Injection in Pediatric Patients With Severe Hemophilia A

Status: Not yet recruiting, Estimated PCD: 2024-12-31

Clinical trial

A Phase I, Multicentre, Open-label Study to Evaluate the Safety and Pharmacokinetic of Recombinant Human Coagulation Factor VIII, Fc Fusion Protein for Injection in Children With Severe Hemophilia A

Status: Completed, Estimated PCD: 2021-11-15